Literature DB >> 11861841

Specific inactivation of inhibitory sequences in the 5' end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells.

Brian Collier1, Daniel Oberg, Xiaomin Zhao, Stefan Schwartz.   

Abstract

The expression of human papillomavirus type 16 late genes encoding virus capsid proteins L1 and L2 is restricted to terminally differentiated epithelial cells in the superficial layers of the squamous epithelium. We wish to understand the molecular mechanisms that determine the levels of expression of the human papillomavirus type 16 late genes. We have previously shown that the L1 coding region contains inhibitory sequences. Here we extend previous findings to show that the 5' end of the L1 gene contains strong inhibitory sequences but that the 3' end does not. We show that the first 514 nucleotides of the L1 coding region contain multiple inhibitory elements that act independently of one another and that the major inhibitory element is located within the first 129 nucleotides of the L1 gene. Introduction of point mutations in the inhibitory elements in the 5' end of the L1 gene which altered the RNA sequence without affecting the protein sequence specifically inactivated the inhibitory elements and resulted in production of high levels of human papillomavirus type 16 L1 mRNA and protein in human epithelial cells. Furthermore, we show that inhibitory sequences are present in the L1 coding regions of multiple human papillomavirus types, demonstrating that these elements are conserved among the human papillomaviruses, and suggest that they have an important function in the viral life cycle.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861841      PMCID: PMC135970          DOI: 10.1128/jvi.76.6.2739-2752.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases.

Authors:  B J Blencowe
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  Inhibitory activity of the human papillomavirus type 1 AU-rich element correlates inversely with the levels of the elav-like HuR protein in the cell cytoplasm.

Authors:  A Carlsson; S Schwartz
Journal:  Arch Virol       Date:  2000       Impact factor: 2.574

Review 3.  Papillomaviruses in human cancers.

Authors:  H zur Hausen
Journal:  Proc Assoc Am Physicians       Date:  1999 Nov-Dec

4.  The inhibitory activity of the AU-rich RNA element in the human papillomavirus type 1 late 3' untranslated region correlates with its affinity for the elav-like HuR protein.

Authors:  M Sokolowski; H Furneaux; S Schwartz
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Production of infectious bovine papillomavirus from cloned viral DNA by using an organotypic raft/xenograft technique.

Authors:  A A McBride; A Dlugosz; C C Baker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

6.  Establishment of the human papillomavirus type 16 (HPV-16) life cycle in an immortalized human foreskin keratinocyte cell line.

Authors:  E R Flores; B L Allen-Hoffmann; D Lee; C A Sattler; P F Lambert
Journal:  Virology       Date:  1999-09-30       Impact factor: 3.616

7.  Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability.

Authors:  J Zhou; W J Liu; S W Peng; X Y Sun; I Frazer
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

8.  The human papillomavirus type 16 negative regulatory RNA element interacts with three proteins that act at different posttranscriptional levels.

Authors:  M D Koffa; S V Graham; Y Takagaki; J L Manley; J B Clements
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

9.  Utilization of the bovine papillomavirus type 1 late-stage-specific nucleotide 3605 3' splice site is modulated by a novel exonic bipartite regulator but not by an intronic purine-rich element.

Authors:  Z M Zheng; E S Reid; C C Baker
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

10.  Two cellular proteins bind specifically to a purine-rich sequence necessary for the destabilization function of a c-fos protein-coding region determinant of mRNA instability.

Authors:  C Y Chen; Y You; A B Shyu
Journal:  Mol Cell Biol       Date:  1992-12       Impact factor: 4.272

View more
  36 in total

1.  Mutational inactivation of two distinct negative RNA elements in the human papillomavirus type 16 L2 coding region induces production of high levels of L2 in human cells.

Authors:  Daniel Oberg; Brian Collier; Xiaomin Zhao; Stefan Schwartz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

2.  Heterogeneous Nuclear Ribonucleoprotein C Proteins Interact with the Human Papillomavirus Type 16 (HPV16) Early 3'-Untranslated Region and Alleviate Suppression of HPV16 Late L1 mRNA Splicing.

Authors:  Soniya Dhanjal; Naoko Kajitani; Jacob Glahder; Ann-Kristin Mossberg; Cecilia Johansson; Stefan Schwartz
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

3.  Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo.

Authors:  Kong-Nan Zhao; WenYi Gu; Ning Xia Fang; Nicholas A Saunders; Ian H Frazer
Journal:  Mol Cell Biol       Date:  2005-10       Impact factor: 4.272

4.  Inhibitory cis-element-mediated decay of human papillomavirus type 16 L1-transcript in undifferentiated cells.

Authors:  Seiichiro Mori; Saori Ozaki; Toshiharu Yasugi; Hiroyuki Yoshikawa; Yuji Taketani; Tadahito Kanda
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

Review 5.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

6.  A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.

Authors:  Daniel Oberg; Joanna Fay; Helen Lambkin; Stefan Schwartz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 5'-splice site of exon 3.

Authors:  Anna Tranell; Eva Maria Fenyö; Stefan Schwartz
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

8.  tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes.

Authors:  Wenyi Gu; Mengrong Li; Wei Ming Zhao; Ning Xia Fang; Shurui Bu; Ian H Frazer; Kong-Nan Zhao
Journal:  Nucleic Acids Res       Date:  2004-08-19       Impact factor: 16.971

Review 9.  Regulation of human papillomavirus gene expression by splicing and polyadenylation.

Authors:  Cecilia Johansson; Stefan Schwartz
Journal:  Nat Rev Microbiol       Date:  2013-03-11       Impact factor: 60.633

10.  Identification of an hnRNP A1-dependent splicing silencer in the human papillomavirus type 16 L1 coding region that prevents premature expression of the late L1 gene.

Authors:  Xiaomin Zhao; Margaret Rush; Stefan Schwartz
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.